Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Einarson, A. Articles by Koren, G. Search for Related Content PubMed Citation Articles by Einarson, A. Articles by Koren, G. Other Childhood Disorders Antidepressants

Pregnancy Outcome Following Gestational Exposure to Venlafaxine: A Multicenter Prospective Controlled Study

OBJECTIVE: Because there are no studies available on the safety of venlafaxine during pregnancy, the authors’ goal in this study was to determine whether venlafaxine increases the risk for major malformations. METHOD: Data on 150 women exposed to venlafaxine during pregnancy in seven pregnancy counseling centers were compared with data from studies of pregnant women who 1) received selective serotonin reuptake inhibitor antidepressants (SSRIs) (N=150) and 2) who received nonteratogenic drugs (N=150). RESULTS: Among the 150 women who were exposed to venlafaxine during pregnancy, 125 had live births, 18 had spontaneous abortions, and seven had therapeutic abortions; two of the babies had major malformations. There were no significant differences between these women and the two comparison groups on any of the measures analyzed. CONCLUSIONS: These results suggest that the use of venlafaxine during pregnancy does not increase the rates of major malformations above the baseline rate of 1%–3%.

This article has been cited by other articles:

				A. Einarson, A. Pistelli, M. DeSantis, H. Malm, W. D. Paulus, A. Panchaud,, D. Kennedy, T. R. Einarson, and G. Koren Evaluation of the Risk of Congenital Cardiovascular Defects Associated With Use of Paroxetine During Pregnancy Am J Psychiatry, June 1, 2008; 165(6): 749 - 752. [Abstract] [Full Text] [PDF]

				E. Ferreira, A. M. Carceller, C. Agogue, B. Z. Martin, M. St-Andre, D. Francoeur, and A. Berard Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During Pregnancy in Term and Preterm Neonates Pediatrics, January 1, 2007; 119(1): 52 - 59. [Abstract] [Full Text] [PDF]

				T. F. Oberlander, W. Warburton, S. Misri, J. Aghajanian, and C. Hertzman Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry, August 1, 2006; 63(8): 898 - 906. [Abstract] [Full Text] [PDF]

				E. L. Moses-Kolko, D. Bogen, J. Perel, A. Bregar, K. Uhl, B. Levin, and K. L. Wisner Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical Applications JAMA, May 18, 2005; 293(19): 2372 - 2383. [Abstract] [Full Text] [PDF]

				M. E. Hemels, A. Einarson, G. Koren, K. L Lanctot, and T. R Einarson Antidepressant Use During Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis Ann. Pharmacother., May 1, 2005; 39(5): 803 - 809. [Abstract] [Full Text] [PDF]

				T. F. Oberlander, R. E. Grunau, C. Fitzgerald, M. Papsdorf, D. Rurak, and W. Riggs Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure Pediatrics, February 1, 2005; 115(2): 411 - 425. [Abstract] [Full Text] [PDF]

				G. Koren Discontinuation Syndrome Following Late Pregnancy Exposure to Antidepressants Arch Pediatr Adolesc Med, April 1, 2004; 158(4): 307 - 308. [Full Text] [PDF]

				D. Kohen Psychotropic medication in pregnancy Adv. Psychiatr. Treat., January 1, 2004; 10(1): 59 - 66. [Abstract] [Full Text] [PDF]

				V. Hendrick and L. Altshuler Management of Major Depression During Pregnancy Am J Psychiatry, October 1, 2002; 159(10): 1667 - 1673. [Full Text] [PDF]

				Venlafaxine in Pregnancy: Cautious Optimism Journal Watch Women's Health, December 17, 2001; 2001(1217): 4 - 4. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us